EFAVIRENZ ASSOCIATED STEVENS-JOHNSON SYNDROME
|
|
- Abigayle Griffith
- 6 years ago
- Views:
Transcription
1 EFAVIRENZ ASSOCIATED STEVENS-JOHNSON SYNDROME To the Editor: Persons with human immunodeficiency virus (HIV) infection are highly susceptible to adverse dermatological reactions to specific medications (1,2). Stevens- Johnson syndrome has been observed in HIV-infected individuals treated with sulfphonamides (3), sulfones (4), thiacetazone (5), and antiretrovirals (6,7). Among the antiretrovirals it is particularly nevirapine that has been associated with this syndrome (6,7). Nevirapine-induced rash has been reported to occur in 32-48% of patients, and Stevens-Johnson syndrome in 1%. Stevens-Johnson syndrome has occasionally been associated with the use of other antiretrovirals such as zidovudine, didanosine, indinavir and amprenavir (2). Its association with the use of efavirenz has been reported in less than 0.14% patients treated with this antiretroviral (2). Case report In August 2003 a 19-year-old Ghanaian woman with HIV infection was admitted with very painful oral lesions. In April 2003 she had been hospitalized for pulmonary tuberculosis. Anti-tuberculosis treatment, including isoniazid, myambutol, pyrazinamide and rifampicin was started, together with cotrimoxazole. Because her CD4+ lymphocyte count was very low (42/µl) highly active antiretroviral treatment (HAART) was added two weeks after the start of the anti-tuberculosis treatment. The HAART regimen included zidovudine, lamivudine and efavirenz. One week later these antiretrovirals were stopped because of fever, increasing dyspnoea, cough and pulmonary infiltrates, probably due to an immune reactivation syndrome. During corticosteroid therapy her clinical condition improved rapidly. Four months later HAART was reintroduced: stavudine 30 mg twice daily, lamivudine 150 mg twice daily and 1
2 efavirenz 600 mg once daily. One week after restarting HAART she developed very painful lesions in her mouth and on the lips. She was admitted because there was trismus; furthermore, she was unable to eat, drink or speak. On admission she had lost 4 kg, and weighed 42 kg. There was a purulent vaginal discharge and urination was very painful. Hemorrhagic ulcerations were present on her lips and in the anal region, she also presented with acute conjunctivitis. Target-like lesions were not observed on her skin, but some erythema was present on the soles of her feet. There was no fever. Laboratory evaluations showed: CD4+ lymphocyte count 12/µl, haemoglobin 12.3 mg/dl, total lymphocytes 880/ml, AST 87 units/l (normal 5-40 U/L), ALT 44 units/l (normal 7-56 U/L). A rapid plasma reagine test for syphilis was negative. A PCR test for Herpes simplex and Mycoplasma pneumoniae performed on a swab from the labial lesions was negative. Further viral, bacterial and fungal cultures of conjunctival and vaginal swabs remained sterile. Based on the presumptive diagnosis of Stevens-Johnson syndrome, efavirenz was discontinued immediately, and stavudine/lamivudine two days later. She received supportive care with intravenous hydration, nasal tube feeding, and corticosteroids. As soon as the efavirenz was discontinued her clinical condition improved and she regained her normal weight. In October 2003 she was re-hospitalized because of a new episode of Stevens-Johnson syndrome with mouth and conjunctiva lesions 7 days after starting dapsone prophylaxis. After stopping the dapsone all lesions disappeared. This patient experienced 2 episodes of Stevens-Johnson syndrome, characterized by mucositis but without characteristic skin lesions. In the first episode the lesions appeared one week after starting antiretroviral treatment and we suspect efavirenz was the cause of this episode. Four months earlier, when an antiretroviral regimen containing efavirenz was started for the first time, she had developed fever, but at that time without mucosal or skin lesions. 2
3 The second episode of Stevens-Johnson syndrome was probably caused by dapsone (a sulfone antimicrobial agent) (4). Stevens-Johnson syndrome is a well-known complication of the other nonnucleoside reverse transcriptase inhibitor, nevirapine. A case control study performed in Europe and Israel identified 18 patients with HIV infection and Stevens-Johnson syndrome, and 15 (83%) of these were considered to be caused by nevirapine (2). One of the 3 other patients had received efavirenz. In this study the nevirapineassociated Stevens-Johnson syndrome began 10 to 240 days after the introduction of nevirapine (median 12 days). The reason why HIV-infected persons are at increased risk of severe cutaneous reactions, including Stevens-Johnson syndrome, remains unclear. The unusual factor in our patient was that despite severe mucositis there was almost no skin involvement. This case suggests that physicians treating persons with HIV infection should also consider a diagnosis of Stevens-Johnson syndrome in patients not on a nevirapinecontaining treatment regimen and presenting only with mucositis. Robert Colebunders 1,2 Thomas Vanwolleghem 1,2 Peter Meurrens 1,2 Filip Moerman 1,2 1. Institute of Tropical Medicine, Nationalestraat 155, B 2000 Antwerp, Belgium 2. University Hospital Antwerp, Wilrijkstraat 10, B , Belgium 3
4 Correspondence : R. Colebunders Institute of Tropical Medicine Nationalestraat 155 B Antwerpen Belgium bcoleb@itg.be 4
5 References 1. Rotunda A, Hirsch RJ, Scheinfeld N, Weinberg JM. Severe cutaneous reactions associated with the use of human immunodeficiency virus medications. Acta Derm Venereol 2003; 3(1): Zangerle R. Cutaneous drug reactions in HIV-infected patients. Dermatol Ther 1999;12: Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167(1): Pertel P, Hischtick R. Adverse reactions to Dapsone in persons infected with human immunodeficiency virus. Clin Infect Dis 1994;18: Nunn P, Kibuga D, Gathua S, Brindle R, Imalingat A, Wasunna K, Lucas S, Gilks C, Omwega M, Were J, et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis. Lancet 1991;337(8742): Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; EuroSCAR Study Group. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. AIDS 2001;15(14): Dodi F, Alessandrini A, Camera M, Gaffuri L, Morandi N, Pagano G. Stevens- Johnson syndrome in HIV patients treated with nevirapine: two case reports. AIDS 2002;16(8):
medical monitoring: clinical monitoring and laboratory tests
medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify
More informationFanconi-like syndrome and rhabdomyolysis in a person with HIV infection. on highly active antiretroviral treatment including tenofovir
1 Letter to the Editor Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir The nucleotide analogue, tenofovir disoproxil
More informationHIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital: A 13-Year Retrospective Review
HIV Clinical Management HIV-Associated Toxic Epidermal Necrolysis at San Francisco General Hospital: A 13-Year Retrospective Review Journal of the International Association of Providers of AIDS Care 2017,
More informationINITIATING ART IN CHILDREN: Follow the six steps
INITIATING ART IN CHILDREN: Follow the six steps STEP 1: DECIDE IF THE CHILD HAS CONFIRMED HIV INFECTION Child < 18 months: HIV infection is confirmed if the PCR is positive and the VL is more than 10,000
More informationEfavirenz, stavudine and lamivudine
efavirenz, stavudine, lamivudine: 1 efavirenz, stavudine and lamivudine First line ART treatment for HIV infection Efavirenz, stavudine and lamivudine efavirenz, stavudine, lamivudine: 2 Slide 1 Information
More informationnevirapine, stavudine and lamivudine
nevirapine, stavudine and lamivudine Information on starting treatment with: nevirapine (NVP) + stavudine (d4t) + lamivudine (3TC) Nevirapine, stavudine and lamivudine (non-fixed dose) 2 Lead in dosing
More informationA Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive Patients
Journal of US-China Medical Science 12 (2015) 85-89 doi: 10.17265/1548-6648/2015.02.008 D DAVID PUBLISHING A Retrospective Study of Spectrum of Nevirapine Induced Cutaneous Drug Reactions in HIV Positive
More informationErythema Multiforme with Reference to Atypical Presentation in an HIV-Positive Patient Following Antiretroviral Therapy Discontinuation
2009;17(1):9-15 CLINICAL ARTICLE Erythema Multiforme with Reference to Atypical Presentation in an HIV-Positive Patient Following Antiretroviral Therapy Discontinuation Liborija Lugović Mihić, Marija Buljan,
More informationnevirapine, zidovudine and lamivudine
nevirapine, zidovudine and lamivudine a fixed dose ART combination for HIV treatment http://www.aidsmap.com/hatip nevirapine. zidovudine and lamivudine (non-fixed dose) 2 Information on starting treatment
More informationThe prevalence of Stevens Johnson Syndrome caused by antiretroviral in hospitalized patients at Dr. Hasan Sadikin General Hospital Bandung
The prevalence of Stevens Johnson Syndrome caused by antiretroviral in hospitalized patients at Dr. Hasan Sadikin General Hospital Bandung Nurmilah Maelani*, Irna Sufiawati*, Hartati Purbo Darmadji** *Department
More informationMedical monitoring: tests available at central hospitals
medial monitoring: tests available at central hospitals: 1 medical monitoring: tests available at central hospitals Medical monitoring: tests available at central hospitals medial monitoring: tests available
More informationIncidence and risk factors for nevirapine-associated rash
Eur J Clin Pharmacol (2003) 59: 457 462 DOI 10.1007/s00228-003-0613-3 PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Monique M. R. de Maat Æ Rob ter Heine Jan W. Mulder Æ Pieter L. Meenhorst Albert T. A. Mairuhu
More informationINTERPROFESSIONAL PROTOCOL - MUHC
INTERPROFESSIONAL PROTOCOL - MUHC Medication included No Medication included THIS IS NOT A MEDICAL ORDER Title: PREVENTION OF MATERNAL TO INFANT HIV INFECTION Intrapartum, Peripartum, and Postpartum Antiretroviral
More informationClinical Case Scenario. HIVeEducation Workshop, Sint Maarten 2009
Clinical Case Scenario HIVeEducation Workshop, Sint Maarten 2009 Background Mrs. S is a 34 year-old woman who was referred from the VCT center after testing HIV positive three weeks ago. Her husband recently
More informationNewly diagnosed HIV patient. Dr. Heila Redpath 06 FEBRUARY 2014
Newly diagnosed HIV patient Dr. Heila Redpath 06 FEBRUARY 2014 PRIMARY HIV INFECTION: SEROCONVERSION SYMPTOMATIC HIV INFECTION AND AIDS ASYMPTOMATIC LATENT INFECTION CLOSED CIRCLES: CD4 cells OPEN
More information0% 0% 0% Parasite. 2. RNA-virus. RNA-virus
HIV/AIDS and Treatment Manado, Indonesia 16 november HIV [e] EDUCATION HIV is a 1. DNA-virus 2. RNA-virus 3. Parasite 0% 0% 0% DNA-virus RNA-virus Parasite HIV HIV is a RNA-virus. HIV is an RNA virus which
More informationABACAVIR HYPERSENSITIVITY REACTION
ABACAVIR HYPERSENSITIVITY REACTION Key Risk Minimisation Points: Abacavir Hypersensitivity Reaction (HSR) Abacavir is associated with a risk for hypersensitivity reactions (HSR) characterised by fever
More informationANTIRETROVIRAL (ART) DRUG INFORMATION FOR HEALTH CARE PROFESSIONAL
ZIDOVUDINE (AZT, Retrovir ) Benefits of zidovudine: Zidovudine (ZDV) is an antiretroviral drug that slows the growth of the HIV virus. It has shown in a large randomized, multicentre study to decrease
More informationElements for a public summary
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Nevirapine is used for antiretroviral combination therapy of Human Immunodeficiency Virus (HIV) infection. Human immunodeficiency
More informationNational Clinical Symposium
National Clinical Symposium Drug Toxicity Workshop September 14-15, 2006 NCHADS Social Health Clinic Case Study NCHADS Social Health Clinic 1 Case study drug toxicity 34 year-old woman, diagnosed HIV +ve+
More informationBACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR
PACKAGE LEAFLET: INFORMATION FOR THE USER BACTRIM tablets CO-TRIMOXAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines
More informationFuture of Pediatrics: Blisters, Hives and Other Tales from the Emergency Room June 14 th, 2016
A. Yasmine Kirkorian MD Assistant Professor of Dermatology & Pediatrics Children s National Health System George Washington University School of Medicine & Health Sciences Future of Pediatrics: Blisters,
More informationOriginal Article. Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah H 1, Tripathi C
Original Article Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: A multicentric retrospective study Barvaliya M, Sanmukhani J, Patel T, Paliwal N, Shah
More informationCorrespondence should be addressed to Wanjarus Roongpisuthipong; rr
Dermatology Research and Practice, Article ID 237821, 5 pages http://dx.doi.org/10.1155/2014/237821 Research Article Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or
More informationHow is it transferred?
STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live
More informationTHE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010
THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES 2010 The South African Antiretroviral Treatment Guidelines 2010 Goals of the programme Achieve best health outcomes in the most cost-efficient manner
More informationWarfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis: a case report
Kasahara et al. BMC Nephrology (2017) 18:237 DOI 10.1186/s12882-017-0648-9 CASE REPORT Open Access Warfarin-induced toxic epidermal necrolysis in combination therapy of Henoch- Schönlein purpura nephritis:
More informationSkin Pathway Group Alemtuzumab in Cutaneous Lymphoma
Skin Pathway Group Alemtuzumab in Cutaneous Lymphoma Indication: Treatment of patients with Cutaneous Lymphoma (Unlicensed use) Disease control prior to Reduced Intensity Conditioning Stem Cell Transplant
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 9 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Nevimune Baby * Nevirapine 50mg Dispersible Tablets Read all of this leaflet carefully before you start giving
More informationHIV medications HIV medication and schedule plan
Living with HIV (human immunodeficiency virus) It may be scary to find out that you re HIV-positive or have AIDS. Coping with this news may be difficult. Although HIV is a serious infection, people with
More informationHIV-associated. infections? Objectives COMMON HIV- ASSOCIATED INFECTIONS
6 HIV-associated infections Before you begin this unit, please take the corresponding test at the end of the book to assess your knowledge of the subject matter. You should redo the test after you ve worked
More informationNevirapine-Induced Side Effects in Pregnant Women Experience of a Brazilian University Hospital
544 BJID 2007; 11 (December) Nevirapine-Induced Side Effects in Pregnant Women Experience of a Brazilian University Hospital William Kondo, Elaine Aparecida Carraro, Elaine Prandel, Josiane Mourão Dias,
More informationINFECTIOUS DISEASES IN THE LONG TERM CARE FACILITY
INFECTIOUS DISEASES IN THE LONG TERM CARE FACILITY The following is a list of the most common infectious diseases that are to be found in the long term care facility. Precautions are recommended and the
More informationContinuing Education for Pharmacy Technicians
Continuing Education for Pharmacy Technicians HIV/AIDS TREATMENT Michael Denaburg, Pharm.D. Birmingham, AL Objectives: 1. Identify drugs and drug classes currently used in the management of HIV infected
More informationImunodeficiency states
Imunodeficiency states Primary Caused by defined genetic defects Usually rare, but severe (exception: IgA deficiency) Secondary Consequence of some other disease, treatment, environmental factors Usually
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: AZATHIOPRINE Protocol number: CV 04 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION LIVER
More informationCardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15
Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15 Indication: RENAL, PANCREAS OR COMBINED RENAL PANCREAS TRANSPLANTATION
More informationTB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011
TB/HIV CO-INFECTION ADULT & CHILDREN (INCLUDING INH PROPHYLAXIS) ART Treatment Guideline Training 31 st January to 4 th February, 2011 OUTLINE Background Global Incidence The Problem" The 3 I s Drug Resistant
More informationHYPERSENSITIVITY REACTIONS
HYPERSENSITIVITY REACTIONS (HSR) TO ABACAVIR / LAMIVUDINE Important risk minimisation material for Healthcare Professionals Risk minimisation material for Abacavir / Lamivudine 1 Introduction Abacavir
More informationGUIDELINES FOR THE USE OF ANTIRETROVIRAL THERAPY IN PAPUA NEW GUINEA
GUIDELINES FOR THE USE OF ANTIRETROVIRAL THERAPY IN PAPUA NEW GUINEA These guidelines were prepared for the Papua New Guinea National AIDS Council and the Papua New Guinea National Department of Health.
More informationTB Intensive Tyler, Texas December 2-4, Tuberculosis and HIV Co-Infection. Lisa Y. Armitige, MD, PhD. December 4, 2008.
TB Intensive Tyler, Texas December 2-4, 2008 Tuberculosis and HIV Co-Infection Lisa Y. Armitige, MD, Ph.D. December 4, 2008 Tuberculosis and HIV Co Infection Lisa Y. Armitige, MD, PhD Assistant Professor
More informationPHCP 403 by L. K. Sarki
PHCP 403 by L. K. Sarki objectives To gain insight into the epidemiology of HIV To gain basic understanding of the etiology of HIV disease To know the clinical manifestations of the disease To gain a basic
More informationYear 2002 Paper two: Questions supplied by Jo 1
Year 2002 Paper two: Questions supplied by Jo 1 Question 9 A 37 year old man with known human immunodeficiency virus (HIV) infection for 10 years presents with severe renal colic for which he has no prior
More informationVIKING STUDIES Efficacy and safety of dolutegravir in treatment-experienced subjects
VIKING STUDIES Efficacy and safety of dolutegravir in treatment-experienced subjects IL/DLG/0040/14 June 2014 GSK (Israel) Ltd. Basel 25, Petach Tikva. Tel-03-9297100 Medical information service: il.medinfo@gsk.com
More informationHIV in Obstetrics and Gynecology
FAST FACTS HIV in Obstetrics and Gynecology Indispensable Guides to Clinical by J Richard Smith, Naomi Low-Beer and Bruce A Barron Practice HIV infection 7 Managing infected women 13 Preconceptual care
More informationChallenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A
Challenging STD Cases Chris Davis, PA-C University of Utah Clinic 1A Case #1 28 year old HIV + MSM presents for first HIV visit with lesion on glans of penis CD4 count of 3 and viral load of 610,000 Multiple
More informationJOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN
JOINT WHO/UNAIDS/UNICEF STATEMENT ON USE OF COTRIMOXAZOLE AS PROPHYLAXIS IN HIV EXPOSED AND HIV INFECTED CHILDREN WHO, UNAIDS and UNICEF, guided by recent evidence, have agreed to modify as an interim
More informationCUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date
CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed
More informationWOMENCARE. Herpes. Source: PDR.net Page 1 of 8. A Healthy Woman is a Powerful Woman (407)
WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Herpes Basics: Herpes is a common viral disease characterized by painful blisters of the mouth or genitals. The herpes simplex virus (HSV) causes
More informationMDR TB/HIV INTEGRATION MDR TB WORKSHOP 18 SEPTEMBER 2015
MDR TB/HIV INTEGRATION MDR TB WORKSHOP 18 SEPTEMBER 2015 HIV & MDR :Impact of early ART initiation Adjusted HR: 0.14; p = 0.042 86% reduction in mortality with ART Initiation during MDR-TB treatment 2015
More informationPneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)
Introduction Pneumocystis Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated
More informationLTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS
LTASEX.INFO STI SUMMARY SHEETS FOR EDUCATIONAL USE ONLY. COMMERCIAL USE RIGHTS RESERVED. COPYRIGHT 2013, JEROME STUART NICHOLS LTASEX.INFO! IN AIDS is a treatable complication of advanced HIV infection.
More informationSTD Notes. Myths about STDs
STD Notes Sexually transmitted diseases (STD's) or sexually transmitted infections (STI's) are infectious diseases that spread from person to person through intimate contact. STD's can affect males and
More informationHIV and AIDS. Shan Nanji
HIV and AIDS Shan Nanji HIV 2 Description: Enveloped Positive Sense HIV 3 Structural Genes: Cleavage of gp160 leads to formation of ENV: Gp120: attachment to host CD4 T Cell Gp41: GAG (p24) Capsid protein
More informationPrinciples of Antiretroviral Therapy
Principles of Antiretroviral Therapy Ten Principles of Antiretroviral Therapy Skills Building Workshop: Clinical Management of HIV Infection and Antiretroviral Therapy, 11 th ICAAP, November 21st, 2011,
More informationTB/HIV Co-Infection. Tuberculosis and HIV
TB Intensive Tyler, Texas June 2-4, 2010 TB/HIV Co-Infection Lisa Y Armitige, MD, PhD June 3, 2010 Tuberculosis and HIV Co-Infection Lisa Y Armitige, MD, PhD Medical Consultant Heartland National TB Center
More informationHIV Update Objectives. Epidemiology. Epidemiology, Transmission and Natural History. Transmission Risk by Exposure. Transmission 9/29/2014
Objectives HIV Update 2014 Jay Sizemore, MD, MPH Medical Director Chattanooga CARES Assistant Professor UTCOM Chattanooga 2October 2014 Review HIV epidemiology and screening/testing guidelines Discuss
More informationConcomitant antiretroviral therapy : Avifanz must be given in combination with other antiretroviral medications.
Avifanz Tablet Description Avifanz is the brand name for Efavirenz. Efavirenz, a synthetic antiretroviral agent, is a non-nucleoside reverse transcriptase inhibitor. While Efavirenz is pharmacologically
More informationCryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease
Cryptococcosis of the Central Nervous System: Classical and Immune-Reconstitution Disease Assist Prof. Somnuek Sungkanuparph Division of Infectious Diseases Faculty of Medicine Ramathibodi Hospital Mahidol
More informationClinical Characteristics and The Selection of Initial ARV Regimen Therapy for HIV-Infected Patients in VCT-CST RSUP Sanglah, Denpasar
Clinical Characteristics and The Selection of Initial ARV Regimen Therapy for HIV-Infected Patients in VCT-CST RSUP Sanglah, Denpasar I G. A. Putu Candradewi, I Ketut Agus Somia Departement of Internal
More informationNCCP Chemotherapy Regimen. Afatinib Therapy
INDICATIONS FOR USE: Afatinib Therapy Regimen Code INDICATION ICD10 Treatment of Epidermal Growth Factor Receptor (EGFR) TKI- naïve adult patients with locally advanced or metastatic non-small cell lung
More information2. Clinical Manifestations (Pediatric HIV Infection)
Page 1 of 6 HOUSTON ROMANIA SOUTHERN AFRICA MEXICO HOME CONTACT Friday, July 25, 2003 Pediatric HIV Infection by Mark W. Kline, M.D. 1. Introduction 2. Clinical Manifestations 3. Diagnosis 2. Clinical
More information1 Introduction. Kenneth Irungu 1 David Nyamu
Drugs - Real World Outcomes (2017) 4:79 85 DOI 10.1007/s40801-017-0105-x ORIGINAL RESEARCH ARTICLE Characterization of Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to
More informationRiTUXimab 375 mg/m 2 Therapy-7 day
RiTUXimab 375 mg/m 2 Therapy-7 day This regimen supercedes NCCP Regimen 00208 rituximab 375mg/m2 therapy-follicular lymphoma as of February 2019 INDICATIONS FOR USE: Regimen *Reimbursement INDICATION ICD10
More informationSEXUALLY TRANSMITTED DISEASES (INFECTIONS)
SEXUALLY TRANSMITTED DISEASES (INFECTIONS) HIV/AIDS - TRANSMISSION Sexual intercourse Anal, oral, & vaginal Multiple partners Sharing needles Mother to infant Born or breast milk Blood transfusions Open
More informationNCCP Chemotherapy Protocol. Afatinib Monotherapy
Afatinib Monotherapy INDICATIONS FOR USE: INDICATION Treatment of Epidermal Growth Factor Receptor (EGFR) TKI- naïve adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
More informationNevirapine 200mg Tablet WHOPAR part 3 May 2005 Updated: May 2016 PACKAGE LEAFLET
PACKAGE LEAFLET PACKAGE LEAFLET Read this entire leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you have further questions, please ask your
More informationMedical monitoring: Clinical monitoring and laboratory tests
medical monitoring: clincial monitoring and laboratory tests: 1 medical monitoring: clinical monitoring and laboratory tests Medical monitoring: Clinical monitoring and laboratory tests Aims This section
More informationTOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY
SAFETY AND TOLERABILITY OF CURRENTLY AVAILABLE ANTIRETROVIRAL AGENTS * Esteban Martinez, MD, PhD ABSTRACT Safety and tolerability are important factors to consider when instituting or modifying therapy
More informationTreatment experience in South Africa. Dr Ian Sanne Clinical HIV Research Unit University of the Witwatersrand
Treatment experience in South Africa Dr Ian Sanne Clinical HIV Research Unit University of the Witwatersrand Overview South African Prevalence Adherence Combination ddi + d4t Nevirapine Hepatotoxicity
More informationRole of Efavirenz in HIV-infected Patients with Preceding Nevirapine-related Skin Rash
Review Article Vol. 24 No. 2 Nevirapine-associated rashes:- Manosuthi W & Sungkanuparph S. 89 Role of Efavirenz in HIV-infected Patients with Preceding Nevirapine-related Skin Rash Weerawat Manosuthi,
More informationMichigan Guidelines: HIV, Syphilis, HBV in Pregnancy
Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy Presenter: Theodore B. Jones, MD Maternal Fetal Medicine Wayne State University School of Medicine Beaumont Dearborn Hospital HIV, Syphilis, HBV in
More informationCare of the HIV-Exposed Infant
Care of the HIV-Exposed Infant Use of Flipchart To promote quality and consistency of counseling Why use the counseling flipchart? To improve HIV-exposed infant outcomes through high quality counseling.
More informationCARBAMAZEPINE INDUCED STEVENS JOHNSON SYNDROME- A CASE STUDY
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ragesh SJIF Impact Factor 2.786 Volume 3, Issue 6, 1599-1604. Case Study ISSN 2278 4357 CARBAMAZEPINE INDUCED STEVENS JOHNSON SYNDROME- A CASE STUDY
More informationNCCP Chemotherapy Regimen. Brentuximab vedotin Monotherapy
Brentuximab INDICATIONS FOR USE: INDICATION ICD10 Regimen Code *Reimbursement Status Treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL): Following autologous stem cell
More informationNursing Interventions
Chapter 16 H I Human Immunodeficiency V Virus A Acquired I Immuno D Deficiency S Syndrome Slide 1 Nursing Interventions Duty to treat Health care professionals may not pick and choose their patients Rehabilitation
More informationManagement of suspected drug-induced rash, kidney injury and liver injury in adult patients on TB treatment and/or antiretroviral treatment
Management of suspected drug-induced rash, kidney injury and liver injury in adult patients on TB treatment and/or antiretroviral treatment April 2018 MEDICINES INFORMATION CENTRE DIVISION OF CLINICAL
More informationSexually Transmitted Infections. Kim Dawson October 2010
Sexually Transmitted Infections Kim Dawson October 2010 Objectives: You will learn about: Sexually Transmitted Infections (STI s). How they are transferred. High risk behavior. The most common STI s. How
More informationLiver Toxicity in Epidemiological Cohorts
SUPPLEMENT ARTICLE Liver Toxicity in Epidemiological Cohorts Stephen Becker Pacific Horizon Medical Group, San Francisco, California Hepatotoxicity has been demonstrated to be associated with antiretroviral
More informationSexually Transmi/ed Diseases
Sexually Transmi/ed Diseases Chapter Fourteen 2013 McGraw-Hill Higher Education. All rights reserved. Also known as sexually transmitted infections The Major STDs (STIs) HIV/AIDS Chlamydia Gonorrhea Human
More informationTB Clinical Guidelines: Revision Highlights March 2014
TB Clinical Guidelines: Revision Highlights March 2014 AIR TRAVEL & TB CONTROL With respect to non-ambulance air travel of patients diagnosed with or suspected as having active Mycobacterium tuberculosis,
More informationThe liver and skin are two of the commonest
AMERICAN ASSOCIATION FOR THE STUDY OFLIVERD I S E ASES HEPATOLOGY, VOL. 63, NO. 3, 2016 LIVER INJURY/REGENERATION Drug-Induced Liver Injury Associated With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis:
More information0.14 ( 0.053%) UNAIDS 10% (94) ( ) (73-94/6 ) 8,920
0.14 UNAIDS 0.053% 2 250 60 10% 94 73 20 73-94/6 8,920 12 43 Public Health Service Task Force Recommendations 5-10% for Use of Antiretroviral Drugs in 10-20% Pregnant HIV-1-Infected Women for Maternal
More informationABACAVIR HYPERSENSITIVITY REACTION
ABACAVIR HYPERSENSITIVITY REACTION Abacavir is a component of Ziagen, Trizivir, Kivexa and Triumeq Triumeq is subject to additional monitoring UK/HIV/0042/15(3) October 2016 Slide Contents CONTENT SLIDES
More informationQuick Study: Sexually Transmitted Infections
Quick Study: Sexually Transmitted Infections Gonorrhea What is it: A bacterial infection of the genitals, anus, or throat. How common: The CDC estimates 820,000 people in the United States get Gonorrhea
More informationTB & HIV CO-INFECTION IN CHILDREN. Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012
TB & HIV CO-INFECTION IN CHILDREN Reené Naidoo Paediatric Infectious Diseases Broadreach Healthcare 19 April 2012 Introduction TB & HIV are two of the leading causes of morbidity & mortality in children
More informationClinical Manifestations of HIV
HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from
More informationFLAMINGO 96-WEEK PRESENTATION DATA
FLAMINGO 96-WEEK PRESENTATION DATA Efficacy and safety of dolutegravir (DTG) in treatment-naïve subjects UK/DLG/0083/14j(4) Date of preparation: August 2017 Prescribing information is available at the
More informationenter the room. Persons immune from previous varicella infection may enter the room without a mask. Those immune by adenoviruses, influenza viruses.
All clients admitted to the hospital automatically are considered to be on standard precautions. The diseases listed below require standard precautions plus additional precautions that are noted in the
More informationThe HIV Program UNIT 2 HIV CURRICULUM PARTICIPANT S MANUAL
T F A R D UNIT 2 The HIV Program UNIT 2 BACKGROUND The HIV Program Poverty and lack of access to basic human rights such as adequate nutrition compound the devastating effects of HIV on communities. Comprehensive
More informationSA TB Guidelines The interface with Advanced Clinical Care
SA TB Guidelines The interface with Advanced Clinical Care Dr Kogie Naidoo (MBCHB, PHD) Head: CAPRISA Treatment Research Programme Honorary Lecturer - UKZN Department of Public Heath Medicine Annual Workshop
More informationWhat is the most important information I should know about tenofovir? What should I discuss with my healthcare provider before taking tenofovir?
1 of 6 6/10/2016 4:33 PM Generic Name: tenofovir (ten OF oh vir) Brand Name: Viread What is tenofovir? Tenofovir is an antiviral medicine that prevents human immunodeficiency virus (HIV) or hepatitis B
More informationHIV/AIDS Update 2007
HIV/AIDS Update 2007 Joanne J. Orrick, Pharm.D., BCPS Clinical Assistant Professor University of Florida Faculty, Florida/Caribbean AIDS Education and Training Center orricjj@ufl.edu www.faetc.org orricjj@ufl.edu
More informationCorrelation of Drug Eruption with the Number of CD4 In the HIV-Infected Patient at Haji Adam Malik General Hospital
International Journal of ChemTech Research CODEN (USA): IJCRGG, ISSN: 0974-4290, ISSN(Online):2455-9555 Vol.11 No.08, pp 297-302, 2018 Correlation of Drug Eruption with the Number of CD4 In the HIV-Infected
More informationREGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES. R e g i S C A R PATIENT'S DATA. Age country of birth
REGISTRY OF SEVERE CUTANEOUS ADVERSE REACTIONS TO DRUGS AND COLLECTION OF BIOLOGICAL SAMPLES R e g i S C A R PATIENT'S DATA Initials of the patient date of birth Age country of birth Gender male female
More informationOral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy
HIV Medicine (2004), 5, 50 54 ORIGINAL RESEARCH r 2004 British HIV Association Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy I Dunic, 1 S Vesic
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More informationROXANE LABORATORIES, INC. VIRAMUNE (nevirapine) Tablets. VIRAMUNE (nevirapine) Oral Suspension. Rx Only WARNING
4077435 079 ROXANE LABORATORIES, INC. VIRAMUNE (nevirapine) Tablets VIRAMUNE (nevirapine) Oral Suspension Rx Only WARNING Severe, life-threatening, and in some cases fatal hepatotoxicity, including fulminant
More informationFLAMINGO 96-WEEK PRESENTATION DATA
FLAMINGO 96-WEEK PRESENTATION DATA Efficacy and safety of dolutegravir (DTG) in treatment-naïve subjects UK/DLG/0083/14j(3) Date of preparation: February 2017 Prescribing information is available at the
More information